Page 19 - Global Blood News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global blood. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Blood Today - Breaking & Trending Today

-$1.20 EPS Expected for Global Blood Therapeutics, Inc. (NASDAQ:GBT) This Quarter

Equities analysts expect Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) to post earnings per share (EPS) of ($1.20) for the current fiscal quarter, Zacks reports. Twelve analysts have made estimates for Global Blood Therapeutics’ earnings. The lowest EPS estimate is ($1.45) and the highest is ($1.02). Global Blood Therapeutics posted earnings of ($1.12) per […] ....

New York , United States , York State Common Retirement Fund , Zacks Investment Research , Thrivent Financial For Lutherans , Global Blood Therapeutics Inc , Cantor Fitzgerald , Advisor Group Holdings Inc , Us Bancorp , Global Blood Therapeutics , Get Rating , Global Blood Therapeutic , Global Blood , Blood Therapeutics , Group Holdings , Capital Management , New York State Common Retirement Fund , Nasdaq Gbt ,

$57.09 Million in Sales Expected for Global Blood Therapeutics, Inc. (NASDAQ:GBT) This Quarter

Equities analysts forecast that Global Blood Therapeutics, Inc. (NASDAQ:GBT – Get Rating) will report sales of $57.09 million for the current fiscal quarter, Zacks Investment Research reports. Eleven analysts have issued estimates for Global Blood Therapeutics’ earnings. The lowest sales estimate is $54.99 million and the highest is $63.40 million. Global Blood Therapeutics reported sales […] ....

William Blair , Morgan Stanley , Huntington National Bank , Zacks Investment Research , Koshinski Asset Management Inc , Lazard Asset Management , Global Blood Therapeutics Inc , Advisor Group Holdings Inc , Global Blood Therapeutics Company Profile Get Rating , Us Bancorp , Global Blood Therapeutics , Get Rating , Global Blood Therapeutic , Blood Therapeutics , Investment Research , Global Blood , National Bank , Asset Management , Group Holdings , Blood Therapeutics Company Profile , Nasdaq Gbt ,